These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 27320334)

  • 1. Computer Simulations of the Retinoid X Receptor: Conformational Dynamics and Allosteric Networks.
    van der Vaart A; Lorkowski A; Ma N; Gray GM
    Curr Top Med Chem; 2017; 17(6):731-741. PubMed ID: 27320334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of a "Gatekeeper" Antagonist that Blocks Entry Pathway to Retinoid X Receptors (RXRs) without Allosteric Ligand Inhibition in Permissive RXR Heterodimers.
    Watanabe M; Fujihara M; Motoyama T; Kawasaki M; Yamada S; Takamura Y; Ito S; Makishima M; Nakano S; Kakuta H
    J Med Chem; 2021 Jan; 64(1):430-439. PubMed ID: 33356247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Promiscuity of Allosteric Regulation of Nuclear Receptors by Retinoid X Receptor.
    Clark AK; Wilder JH; Grayson AW; Johnson QR; Lindsay RJ; Nellas RB; Fernandez EJ; Shen T
    J Phys Chem B; 2016 Aug; 120(33):8338-45. PubMed ID: 27110634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective allosteric ligand activation of the retinoid X receptor heterodimers of NGFI-B and Nurr1.
    Morita K; Kawana K; Sodeyama M; Shimomura I; Kagechika H; Makishima M
    Biochem Pharmacol; 2005 Dec; 71(1-2):98-107. PubMed ID: 16288995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers.
    Vivat V; Zechel C; Wurtz JM; Bourguet W; Kagechika H; Umemiya H; Shudo K; Moras D; Gronemeyer H; Chambon P
    EMBO J; 1997 Sep; 16(18):5697-709. PubMed ID: 9312028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A regulatory role for RIP140 in nuclear receptor activation.
    Treuter E; Albrektsen T; Johansson L; Leers J; Gustafsson JA
    Mol Endocrinol; 1998 Jun; 12(6):864-81. PubMed ID: 9626662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural insights into the heterodimeric complex of the nuclear receptors FXR and RXR.
    Zheng W; Lu Y; Tian S; Ma F; Wei Y; Xu S; Li Y
    J Biol Chem; 2018 Aug; 293(32):12535-12541. PubMed ID: 29934308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corepressor interaction differentiates the permissive and non-permissive retinoid X receptor heterodimers.
    Lammi J; Perlmann T; Aarnisalo P
    Arch Biochem Biophys; 2008 Apr; 472(2):105-14. PubMed ID: 18282463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators.
    Westin S; Kurokawa R; Nolte RT; Wisely GB; McInerney EM; Rose DW; Milburn MV; Rosenfeld MG; Glass CK
    Nature; 1998 Sep; 395(6698):199-202. PubMed ID: 9744281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinoid X receptors: common heterodimerization partners with distinct functions.
    Lefebvre P; Benomar Y; Staels B
    Trends Endocrinol Metab; 2010 Nov; 21(11):676-83. PubMed ID: 20674387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allosteric interaction of the 1alpha,25-dihydroxyvitamin D3 receptor and the retinoid X receptor on DNA.
    Kahlen JP; Carlberg C
    Nucleic Acids Res; 1997 Nov; 25(21):4307-13. PubMed ID: 9336462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterodimer formation by retinoid X receptor: regulation by ligands and by the receptor's self-association properties.
    Dong D; Noy N
    Biochemistry; 1998 Jul; 37(30):10691-700. PubMed ID: 9692959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR.
    Egea PF; Rochel N; Birck C; Vachette P; Timmins PA; Moras D
    J Mol Biol; 2001 Mar; 307(2):557-76. PubMed ID: 11254382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamical probing of allosteric control in nuclear receptors.
    Cunningham MA
    J Mol Model; 2012 Jul; 18(7):3147-52. PubMed ID: 22222612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoid X receptors: X-ploring their (patho)physiological functions.
    Szanto A; Narkar V; Shen Q; Uray IP; Davies PJ; Nagy L
    Cell Death Differ; 2004 Dec; 11 Suppl 2():S126-43. PubMed ID: 15608692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand Design for Modulation of RXR Functions.
    Martínez C; Souto JA; de Lera AR
    Methods Mol Biol; 2019; 2019():51-72. PubMed ID: 31359388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The retinoid X receptor and its ligands: versatile regulators of metabolic function, cell differentiation and cell death.
    Ahuja HS; Szanto A; Nagy L; Davies PJ
    J Biol Regul Homeost Agents; 2003; 17(1):29-45. PubMed ID: 12757020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unique response pathways are established by allosteric interactions among nuclear hormone receptors.
    Forman BM; Umesono K; Chen J; Evans RM
    Cell; 1995 May; 81(4):541-50. PubMed ID: 7758108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individual subunits of heterodimers comprised of retinoic acid and retinoid X receptors interact with their ligands independently.
    Kersten S; Dawson MI; Lewis BA; Noy N
    Biochemistry; 1996 Mar; 35(12):3816-24. PubMed ID: 8620004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoid X receptor is a nonsilent major contributor to vitamin D receptor-mediated transcriptional activation.
    Bettoun DJ; Burris TP; Houck KA; Buck DW; Stayrook KR; Khalifa B; Lu J; Chin WW; Nagpal S
    Mol Endocrinol; 2003 Nov; 17(11):2320-8. PubMed ID: 12893883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.